The promoters of generic injectables maker Claris Lifesciences, on Monday, transferred their entire 60.21% stake in the company to two companies — in which Claris CEO Arjun Handa and director Aditya Handa hold the majority stake.
The buyers are Athanas Enterprise and Abellon Energy, according to stock exchange block deal data.
Arjun holds 99.9% of Athanas total share capital while Aditya holds, directly and indirectly, a stake of 88.15% in Abellon Energy, according to a BSE filing dated December 20.
The four promoters of the Ahmedabad-based company are the Handa brothers, Medical Technologies and Sarjan Financial.
The transfer of the 60.21% stake consisted of about 3.8 crore shares for a total consideration of R801 crore, with 2.8 crores priced at R204.7 each and the remaining at R219.1 apiece.
Claris Lifesciences Ltd' share price rose as much as 15.4% to Rs 229 before closing down 2.09% at Rs 194.30 on the Bombay Stock Exchange on Monday.